Clinical Laserthermia Systems Americas, Inc.

Clinical Laserthermia Systems Americas, Inc., a for-profit Subchapter S corporation and manufacturer of surgical and medical instruments based in Irvine, California, sells interventional radiology consumables and clinical laserthermia systems to the federal government as a prime contractor on purchase orders and as a sub-recipient on federal research grants. The vendor holds no small-business set-aside designations and competes full-and-open.

Clinical Laserthermia Systems' federal footprint is concentrated in the Department of Health and Human Services — specifically the National Institutes of Health Clinical Center and the National Cancer Institute — and remains nascent. Two prime purchase orders with the NIH Clinical Center account for $114 thousand in combined potential value: a $79,125 firm fixed price order awarded May 30, 2023 for clinical laserthermia systems for prostate ablation with ultimate completion November 30, 2023, and a $34,800 purchase order awarded March 26, 2024 for interventional radiology consumables for Florida prostate ablation procedures with ultimate completion July 31, 2026. Performance occurs at the vendor's Irvine, California facility. As a sub-recipient, Clinical Laserthermia Systems received a federal research grant award from the National Cancer Institute (prime grantee: Dartmouth-Hitchcock Clinic) dated October 12, 2026, supporting preclinical laser-induced thermal therapy (LITT) studies in a porcine model for treatment of spinal metastases. The vendor has received three total awards across three separate years (2023, 2024, 2026) with combined dollars obligated at $163 thousand, exceeding combined potential value. Clinical Laserthermia Systems does not hold a parent contract vehicle seat and has not been awarded an IDIQ, GWAC, BPA, or agency-wide schedule.